Shanghai Henlius Biotech Gestione
Gestione criteri di controllo 2/4
Shanghai Henlius Biotech's CEO is Jason Zhu, appointed in Jul 2023, has a tenure of 1.33 years. total yearly compensation is CN¥9.26M, comprised of 87.8% salary and 12.2% bonuses, including company stock and options. directly owns 0.009% of the company’s shares, worth HK$1.09M. The average tenure of the management team and the board of directors is 2.3 years and 5.2 years respectively.
Informazioni chiave
Jason Zhu
Amministratore delegato
CN¥9.3m
Compenso totale
Percentuale dello stipendio del CEO | 87.8% |
Mandato del CEO | 1.3yrs |
Proprietà del CEO | 0.009% |
Durata media del management | 2.3yrs |
Durata media del Consiglio di amministrazione | 5.2yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Is Shanghai Henlius Biotech (HKG:2696) Using Too Much Debt?
May 25Shanghai Henlius Biotech, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Mar 25Shanghai Henlius Biotech, Inc.'s (HKG:2696) Price Is Right But Growth Is Lacking
Mar 10Here's Why Shanghai Henlius Biotech (HKG:2696) Is Weighed Down By Its Debt Load
Dec 31The Strong Earnings Posted By Shanghai Henlius Biotech (HKG:2696) Are A Good Indication Of The Strength Of The Business
Nov 25Is Shanghai Henlius Biotech (HKG:2696) Using Too Much Debt?
Sep 18Improved Revenues Required Before Shanghai Henlius Biotech, Inc. (HKG:2696) Shares Find Their Feet
Aug 03Shanghai Henlius Biotech (HKG:2696) Has Debt But No Earnings; Should You Worry?
May 31Need To Know: Analysts Are Much More Bullish On Shanghai Henlius Biotech, Inc. (HKG:2696) Revenues
Apr 06Is Shanghai Henlius Biotech (HKG:2696) Using Too Much Debt?
Sep 22Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Jun 30 2024 | n/a | n/a | CN¥692m |
Mar 31 2024 | n/a | n/a | CN¥619m |
Dec 31 2023 | CN¥9m | CN¥8m | CN¥546m |
Compensazione vs Mercato: Jason's total compensation ($USD1.31M) is above average for companies of similar size in the Hong Kong market ($USD496.15K).
Compensazione vs guadagni: Insufficient data to compare Jason's compensation with company performance.
AMMINISTRATORE DELEGATO
Jason Zhu (45 yo)
1.3yrs
Mandato
CN¥9,261,000
Compensazione
Dr. Jun Zhu, also known as Jason, had been Chief Financial Officer at Shanghai Henlius Biotech, Inc. since May 1, 2023 until July 1, 2024 and served as its President since November 30, 2021 until October 1...
Gruppo dirigente
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Executive Chairman of the Board | 4.8yrs | CN¥12.58m | Nessun dato | |
CEO & Executive Director | 1.3yrs | CN¥9.26m | 0.0092% HK$ 1.1m | |
President | 1.1yrs | Nessun dato | Nessun dato | |
Co-founder & Head of Strategy Advisory Committee | 14.8yrs | CN¥6.21m | 0.44% HK$ 52.6m | |
Co-Founder & Co-Head of Innovative Advisory Committee | 14.8yrs | Nessun dato | 0.13% HK$ 15.7m | |
VP & CFO | less than a year | Nessun dato | Nessun dato | |
CTO & Senior VP | 1.9yrs | Nessun dato | Nessun dato | |
Vice President of Legal & Compliance Department | 1.8yrs | Nessun dato | Nessun dato | |
Deputy GM of Public Relations & Joint Company Secretary | 3yrs | Nessun dato | Nessun dato | |
VP of Sales & Oncology Business Unit | 4.8yrs | Nessun dato | Nessun dato | |
VP & Chief Human Resource Officer | 2.6yrs | Nessun dato | Nessun dato | |
Senior Vice President | no data | Nessun dato | Nessun dato |
2.3yrs
Durata media
52yo
Età media
Gestione esperta: 2696's management team is considered experienced (2.3 years average tenure).
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Executive Chairman of the Board | 4.8yrs | CN¥12.58m | Nessun dato | |
CEO & Executive Director | 1.3yrs | CN¥9.26m | 0.0092% HK$ 1.1m | |
Independent Non-Executive Director | 5.2yrs | CN¥258.00k | Nessun dato | |
Non-Executive Director | 11.8yrs | Nessun dato | Nessun dato | |
Independent Non-Executive Director | 5.2yrs | CN¥258.00k | Nessun dato | |
Non-Executive Director | 5.9yrs | Nessun dato | Nessun dato | |
Member of Scientific Advisory Board | 1.3yrs | Nessun dato | Nessun dato | |
Non-Executive Director | 9.4yrs | Nessun dato | Nessun dato | |
Non-Executive Director | 2.3yrs | Nessun dato | Nessun dato | |
Independent Non-Executive Director | 5.2yrs | CN¥258.00k | Nessun dato | |
Independent Non-Executive Director | 5.2yrs | CN¥258.00k | Nessun dato | |
Chairman of Supervisory Board | 4.6yrs | Nessun dato | Nessun dato |
5.2yrs
Durata media
53yo
Età media
Consiglio di amministrazione esperto: 2696's board of directors are considered experienced (5.2 years average tenure).